Kratom & Pain Research: What Do Preclinical Data Show?
Mitragynine and analgesia in animal models
Mitragynine shows analgesic effects in several animal models:
- Tail-flick test and hot-plate test (thermal pain models): extended reaction latency in mice and rats
- Writhing test (chemically induced visceral pain): dose-dependent reduction
- Formalin test (inflammatory pain model in rodents): measurable effect in both phases
In these models the analgesic effect was partially reversed by the μ-opioid antagonist naloxone – indicating opioid-mediated analgesia.
7-OH-mitragynine: greater potency, lower availability
In rodent models, 7-hydroxymitragynine was measured as more potent than mitragynine; some models cite magnitudes in the range of morphine. These comparisons apply to the respective animal model, not to humans. Since it occurs in the leaf only in very small amounts, its contribution to the overall profile is unclear.
Tolerance and dependence in animal models
As with classical opioids, tolerance develops under regular mitragynine administration. Withdrawal signs after discontinuation were observed – but are regarded as milder than with morphine.
The decisive question: transferability
Preclinical data show a pharmacological mechanism – they say nothing conclusive about clinical efficacy in humans. Limitations: doses are not directly scalable; kratom is a plant mixture, not a standardized pure substance; individual differences are considerable.
Conclusion
Preclinical data consistently show analgesic properties of mitragynine and 7-hydroxymitragynine via opioid-mediated mechanisms. Clinical data in humans are largely absent. The gap between "works in the mouse" and "works clinically in humans" is real – but the mechanism is plausible enough to justify systematic clinical study.
This article describes preclinical research data. It makes no statement about clinical efficacy in humans. Our goods are not intended for consumption.
Further reading
- Kratom and Sleep: Withdrawal, REM Sleep and the State of Research
- Kratom & Opioid Withdrawal: What the Research Shows – and What Self-Reports Cannot Prove
- What Is Buprenorphine? And Why Is the Comparison to Kratom Important?
- Without animal-derived components: what our goods are made of
Legal notice
This article is for informational purposes only and does not constitute legal advice. Its content is not intended to encourage consumption. Laws may change; the applicable regulations and information from official bodies are authoritative. Image source: https://www.kratoein.com/